Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 4/2016

01-04-2016 | Gastrointestinal Oncology

Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the U.S. Gastric Cancer Collaborative

Authors: Aaron U. Blackham, MD, Doug S. Swords, MD, Edward A. Levine, MD, Nora F. Fino, MS, Malcolm H. Squires, MD, George Poultsides, MD, Ryan C. Fields, MD, Mark Bloomston, MD, Sharon M. Weber, MD, Timothy M. Pawlik, MD, MPH, PhD, Linda X. Jin, MD, Gaya Spolverato, MD, Carl Schmidt, MD, David Worhunsky, MD, Clifford S. Cho, MD, Shishir K. Maithel, MD, Konstantinos I. Votanopoulos, MD, Phd, FACS

Published in: Annals of Surgical Oncology | Issue 4/2016

Login to get access

Abstract

Background

Current staging and treatment guidelines for gastric adenocarcinoma do not differentiate between linitis plastic (LP) and non-LP cancers. Significant controversy exists regarding the surgical management of LP patients.

Methods

Using the multi-institutional U.S. Gastric Cancer Collaborative database, 869 gastric cancer patients who underwent resection between 2000 and 2012 were identified. Clinicopathologic and outcomes data of 58 LP patients were compared to 811 non-LP patients.

Results

Stage III/IV disease was more common at presentation in LP patients compared with non-LP patients (90 vs. 44 %, p < 0.01). Despite the fact that most LP patients underwent total gastrectomy (88 vs. 39 %, p < 0.01), final positive margins were more common in LP patients (33 vs. 7 %, p < 0.01). The use of frozen section allowed 15 intraoperative positive margins in 38 patients to be converted to negative final margins. Median overall survival (OS) was significantly worse in patients with LP (11.6 vs. 37.8 months, p < 0.01). There was no difference in median OS of LP patients based on stage (I/II, 17.3 mo; III, 10.6 mo; IV, 12.0 mo; p = 0.46). LP and non-LP patients who underwent optimal resection (negative margin and D2/3 lymphadenectomy) had better survival compared with those with nonoptimal resections. The median OS for optimally resected stage III LP (n = 22) and stage III non-LP (n = 185) patients was nearly identical (26.7 vs. 25.3 mo; p = 0.69).

Conclusions

Future staging systems and treatment guidelines should differentiate between LP and non-LP gastric cancers. Long-term survival in select LP patients who undergo optimal resections is comparable to optimally resected non-LP patients.
Literature
1.
Bollschweiler E, Boettcher K, Hoelscher AH, et al. Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer. 1993;71(10):2918–2925.CrossRefPubMed
2.
Schauer M, Peiper M, Theisen J, Knoefel W. Prognostic factors in patients with diffuse type gastric cancer (linitis plastica) after operative treatment. Eur J Med Res. 2011;16(1):29–33.CrossRefPubMedPubMedCentral
3.
Mastoraki A, Papanikolaou IS, Sakorafas G, Safioleas M. Facing the challenge of managing linitis plastica: review of the literature. Hepatogastroenterol. 2009;56(96):1773–1778.
4.
An JY, Kang TH, Choi MG, Noh JH, Sohn TS, Kim S. Borrmann type IV: an independent prognostic factor for survival in gastric cancer. J Gastrointest Surg. 2008;12(8):1364–1369.CrossRefPubMed
5.
Kodera Y, Ito S, Mochizuki Y, et al. The number of metastatic lymph nodes is a significant risk factor for bone metastasis and poor outcome after surgery for linitis plastica-type gastric carcinoma. World J Surg. 2008;32(9):2015–2020.CrossRefPubMed
6.
Pedrazzani C, Marrelli D, Pacelli F, et al. Gastric linitis plastica: which role for surgical resection? Gastric Cancer. 2012;15(1):56–60.CrossRefPubMed
7.
Kitamura K, Beppu R, Anai H, et al. Clinicopathological study of patients with borrmann type IV gastric carcinoma. J Surg Oncol. 1995;58(2):112–117.CrossRefPubMed
8.
Hamy A, Letessier E, Bizouarn P, et al. Study of survival and prognostic factors in patients undergoing resection for gastric linitis plastica: a review of 86 cases. Int Surg. 1999;84(4):337–343.PubMed
9.
Aranha GV, Georgen R. Gastric linitis plastica is not a surgical disease. Surgery. 1989;106(4):758-62; (discussion 762–763).PubMed
10.
Otsuji E, Kuriu Y, Okamoto K, et al. Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach. Am J Surg. 2004;188(3):327–32.CrossRefPubMed
11.
Takahashi I, Matsusaka T, Onohara T, et al. Clinicopathological features of long-term survivors of scirrhous gastric cancer. Hepatogastroenterol. 2000;47(35):1485–1488.
12.
Spolverato G, Ejaz A, Kim Y, et al. Rates and Patterns of Recurrence after Curative Intent Resection for Gastric Cancer: a United States multi-institutional analysis. J Am Coll Surg. 2014;219(4):664–675.CrossRefPubMed
13.
Ejaz A, Spolverato G, Kim Y, et al. Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis. Ann Surg Oncol. 2014;21(11):3412–3421.CrossRefPubMed
14.
Edge S, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual, 7th ed. Springer, New york; 2010.
15.
Japanese Gastric Canc A. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113–123.CrossRef
16.
Wang JP, Dang P, Raut CP, et al. Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer analysis of 18,043 patients from the SEER Database. Ann Surg. 2012;255(3):478–485.CrossRefPubMed
17.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213.CrossRefPubMedPubMedCentral
18.
Jafferbhoy S, Shiwani H, Rustum Q. Managing gastric linitis plastica: Keep the scalpel sheathed. Sultan Qaboos University Med J. 2013;13(3):451–453.CrossRef
19.
Furukawa H, Hiratsuka M, Iwanaga T. A rational technique for surgical operation on Borrmann type 4 gastric-carcinoma—left upper abdominal evisceration plus Applebys method. Br J Surg. 1988;75(2):116–119.CrossRefPubMed
20.
Kodera Y, Yamamura Y, Ito S, et al. Borrmann type IV gastric carcinoma a surgical disease? An old problem revisited with reference to the result of peritoneal washing cytology. J Surg Oncol. 2001;78(3):175–181.CrossRefPubMed
21.
Kodera Y, Yamamura Y, Torri A, et al. Surgical treatment of Borrmann type IV gastric carcinoma: relevance of lymphadenectomy in improving survival. J Am Coll Surg. 1996;183(5):480–485.PubMed
22.
Yamashita K, Hosoda K, Katada N, et al. Survival outcome of Borrmann type IV gastric cancer potentially improved by multimodality treatment. Anticancer Res. 2015;35(2):897–906.PubMed
23.
Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20.CrossRefPubMed
24.
Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725–730.CrossRefPubMed
25.
Sasaki T, Koizumi W, Tanabe S, Higuchi K, Nakayama N, Saigenji K. TS-1 as first-line therapy for gastric linitis plastica: historical control study. Anticancer drugs. 2006;17(5):581–586.CrossRefPubMed
26.
Iwasaki Y, Sasako M, Yamamoto S, et al. Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol. 2013;107(7):741–745.CrossRefPubMed
27.
Kinoshita T, Sasako M, Sano T, et al. Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002). Gastric Cancer. 2009;12(1):37–42.CrossRefPubMed
Metadata
Title
Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the U.S. Gastric Cancer Collaborative
Authors
Aaron U. Blackham, MD
Doug S. Swords, MD
Edward A. Levine, MD
Nora F. Fino, MS
Malcolm H. Squires, MD
George Poultsides, MD
Ryan C. Fields, MD
Mark Bloomston, MD
Sharon M. Weber, MD
Timothy M. Pawlik, MD, MPH, PhD
Linda X. Jin, MD
Gaya Spolverato, MD
Carl Schmidt, MD
David Worhunsky, MD
Clifford S. Cho, MD
Shishir K. Maithel, MD
Konstantinos I. Votanopoulos, MD, Phd, FACS
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 4/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4947-8

Other articles of this Issue 4/2016

Annals of Surgical Oncology 4/2016 Go to the issue

Hepatobiliary Tumors

Should ALPPS be Used for Liver Resection in Intermediate-Stage HCC?

Gastrointestinal Oncology

Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric Adenocarcinoma

Melanomas

The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case–Control Study

Endocrine Tumors

Open Versus Laparoscopic Adrenalectomy for Adrenocortical Carcinoma: A Meta-analysis of Surgical and Oncological Outcomes

Colorectal Cancer

Effect of High-Grade Disease on Outcomes of Surgically Treated Colon Cancer

Hepatobiliary Tumors

Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases